Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Coagulation factor VII | ||
Ligand | BDBM50032881 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1443464 (CHEMBL3377178) | ||
Ki | >10900±n/a nM | ||
Citation | Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity. J Med Chem57:9915-32 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Coagulation factor VII | |||
Name: | Coagulation factor VII | ||
Synonyms: | Eptacog alfa | F7 | FA7_HUMAN | Factor VIIa | Factor VIIa (fVIIa) | Proconvertin | SPCA | Thrombin and coagulation factor VII | serum prothrombin conversion accelerator | ||
Type: | Enzyme | ||
Mol. Mass.: | 51599.89 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50032881 | |||
n/a | |||
Name | BDBM50032881 | ||
Synonyms: | CHEMBL3355676 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H32F3N5O4 | ||
Mol. Mass. | 559.58 | ||
SMILES | OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1cccc(c1)C(N)=O |r,wU:18.18,12.14,wD:9.7,(29.77,-17.68,;31.11,-18.45,;31.11,-19.99,;32.44,-17.68,;33.78,-18.45,;33.77,-16.89,;32.44,-16.14,;13.69,-24.66,;15.02,-25.44,;16.36,-24.67,;17.7,-25.45,;19.04,-24.68,;19.03,-23.14,;17.7,-22.37,;16.36,-23.13,;20.36,-22.37,;20.36,-20.83,;21.69,-23.14,;23.03,-22.37,;23.03,-20.83,;24.37,-20.06,;25.7,-20.83,;27.03,-20.07,;27.03,-18.52,;25.69,-17.75,;24.36,-18.53,;24.36,-23.14,;25.77,-22.51,;26.8,-23.65,;26.03,-24.99,;24.52,-24.67,;28.32,-23.5,;28.94,-22.09,;30.47,-21.93,;31.39,-23.18,;30.76,-24.58,;29.23,-24.74,;31.67,-25.83,;31.04,-27.24,;33.2,-25.67,)| | ||
Structure |